Ted White

Insider Reports History

Location
West Chester, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ted White:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. PRESIDENT AND CEO, Director Common Stock 215,967 $531,279 $2.46 27 Aug 2024 Direct
Verrica Pharmaceuticals Inc. PRESIDENT AND CEO, Director Employee Stock Option (right to buy) 225,000 15 Mar 2024 Direct

Insider Reports Filed by Ted White

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRCA Verrica Pharmaceuticals Inc. 26 Aug 2024 2 -$88,636 4 PRESIDENT AND CEO, Director 28 Aug 2024, 16:15
VRCA Verrica Pharmaceuticals Inc. 22 Jul 2024 2 -$230,306 4 PRESIDENT AND CEO, Director 23 Jul 2024, 18:13
VRCA Verrica Pharmaceuticals Inc. 15 Mar 2024 2 $0 4 PRESIDENT AND CEO, Director 19 Mar 2024, 16:31
VRCA Verrica Pharmaceuticals Inc. 14 Nov 2023 2 -$99,200 4 President and CEO, Director 16 Nov 2023, 16:33
VRCA Verrica Pharmaceuticals Inc. 24 Aug 2023 1 $0 4/A PRESIDENT AND CEO, Director 06 Feb 2025, 16:15
VRCA Verrica Pharmaceuticals Inc. 21 Jul 2023 2 -$244,770 4 President and CEO, Director 25 Jul 2023, 16:18
VRCA Verrica Pharmaceuticals Inc. 01 Mar 2023 1 $0 4 President and CEO, Director 03 Mar 2023, 15:29
VRCA Verrica Pharmaceuticals Inc. 05 Jul 2022 1 +$15,750 4/A President and CEO, Director 21 Feb 2023, 15:08
VRCA Verrica Pharmaceuticals Inc. 24 Feb 2022 1 $0 4 President and CEO, Director 25 Feb 2022, 15:30
VRCA Verrica Pharmaceuticals Inc. 04 Jun 2021 1 +$39,800 4 President and CEO, Director 07 Jun 2021, 08:44